Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy

A. Sivaraman, G. Ordaz Jurado, X. Cathelineau, Eric Barret, P. Dell’Oglio, S. Joniau, M. Bianchi, A. Briganti, M. Spahn, P. Bastian, J. Chun, P. Chlosta, P. Gontero, M. Graefen, Robert Jeffrey Karnes, G. Marchioro, B. Tombal, L. Tosco, H. Henk van der Poel, R. Sanchez-Salas

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction: The aim of the study was to identify the appropriate level of Charlson comorbidity index (CCI) in older patients (>70 years) with high-risk prostate cancer (PCa) to achieve survival benefit following radical prostatectomy (RP). Methods: We retrospectively analyzed 1008 older patients (>70 years) who underwent RP with pelvic lymph node dissection for high-risk prostate cancer (preoperative prostate-specific antigen >20 ng/mL or clinical stage ≥T2c or Gleason ≥8) from 14 tertiary institutions between 1988 and 2014. The study population was further grouped into CCI <2 and ≥2 for analysis. Survival rate for each group was estimated with Kaplan–Meier method and competitive risk Fine-Gray regression to estimate the best explanatory multivariable model. Area under the curve (AUC) and Akaike information criterion were used to identify ideal ‘Cut off’ for CCI. Results: The clinical and cancer characteristics were similar between the two groups. Comparison of the survival analysis using the Kaplan–Meier curve between two groups for non-cancer death and survival estimations for 5 and 10 years shows significant worst outcomes for patients with CCI ≥ 2. In multivariate model to decide the appropriate CCI cut-off point, we found CCI 2 has better AUC and p value in log rank test. Conclusion: Older patients with fewer comorbidities harboring high-risk PCa appears to benefit from RP. Sicker patients are more likely to die due to non-prostate cancer-related causes and are less likely to benefit from RP.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalWorld Journal of Urology
DOIs
StateAccepted/In press - Feb 20 2016
Externally publishedYes

Fingerprint

Prostatectomy
Comorbidity
Prostatic Neoplasms
Area Under Curve
Survival
Prostate-Specific Antigen
Survival Analysis
Lymph Node Excision
Neoplasms
Survival Rate
Population

Keywords

  • Charlson comorbidity index
  • High-risk prostate cancer
  • Radical prostatectomy
  • Survival benefit

ASJC Scopus subject areas

  • Urology

Cite this

Sivaraman, A., Ordaz Jurado, G., Cathelineau, X., Barret, E., Dell’Oglio, P., Joniau, S., ... Sanchez-Salas, R. (Accepted/In press). Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. World Journal of Urology, 1-6. https://doi.org/10.1007/s00345-016-1784-8

Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. / Sivaraman, A.; Ordaz Jurado, G.; Cathelineau, X.; Barret, Eric; Dell’Oglio, P.; Joniau, S.; Bianchi, M.; Briganti, A.; Spahn, M.; Bastian, P.; Chun, J.; Chlosta, P.; Gontero, P.; Graefen, M.; Karnes, Robert Jeffrey; Marchioro, G.; Tombal, B.; Tosco, L.; van der Poel, H. Henk; Sanchez-Salas, R.

In: World Journal of Urology, 20.02.2016, p. 1-6.

Research output: Contribution to journalArticle

Sivaraman, A, Ordaz Jurado, G, Cathelineau, X, Barret, E, Dell’Oglio, P, Joniau, S, Bianchi, M, Briganti, A, Spahn, M, Bastian, P, Chun, J, Chlosta, P, Gontero, P, Graefen, M, Karnes, RJ, Marchioro, G, Tombal, B, Tosco, L, van der Poel, HH & Sanchez-Salas, R 2016, 'Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy', World Journal of Urology, pp. 1-6. https://doi.org/10.1007/s00345-016-1784-8
Sivaraman, A. ; Ordaz Jurado, G. ; Cathelineau, X. ; Barret, Eric ; Dell’Oglio, P. ; Joniau, S. ; Bianchi, M. ; Briganti, A. ; Spahn, M. ; Bastian, P. ; Chun, J. ; Chlosta, P. ; Gontero, P. ; Graefen, M. ; Karnes, Robert Jeffrey ; Marchioro, G. ; Tombal, B. ; Tosco, L. ; van der Poel, H. Henk ; Sanchez-Salas, R. / Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. In: World Journal of Urology. 2016 ; pp. 1-6.
@article{bb9affcbffcd40149f247b856ceb6150,
title = "Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy",
abstract = "Introduction: The aim of the study was to identify the appropriate level of Charlson comorbidity index (CCI) in older patients (>70 years) with high-risk prostate cancer (PCa) to achieve survival benefit following radical prostatectomy (RP). Methods: We retrospectively analyzed 1008 older patients (>70 years) who underwent RP with pelvic lymph node dissection for high-risk prostate cancer (preoperative prostate-specific antigen >20 ng/mL or clinical stage ≥T2c or Gleason ≥8) from 14 tertiary institutions between 1988 and 2014. The study population was further grouped into CCI <2 and ≥2 for analysis. Survival rate for each group was estimated with Kaplan–Meier method and competitive risk Fine-Gray regression to estimate the best explanatory multivariable model. Area under the curve (AUC) and Akaike information criterion were used to identify ideal ‘Cut off’ for CCI. Results: The clinical and cancer characteristics were similar between the two groups. Comparison of the survival analysis using the Kaplan–Meier curve between two groups for non-cancer death and survival estimations for 5 and 10 years shows significant worst outcomes for patients with CCI ≥ 2. In multivariate model to decide the appropriate CCI cut-off point, we found CCI 2 has better AUC and p value in log rank test. Conclusion: Older patients with fewer comorbidities harboring high-risk PCa appears to benefit from RP. Sicker patients are more likely to die due to non-prostate cancer-related causes and are less likely to benefit from RP.",
keywords = "Charlson comorbidity index, High-risk prostate cancer, Radical prostatectomy, Survival benefit",
author = "A. Sivaraman and {Ordaz Jurado}, G. and X. Cathelineau and Eric Barret and P. Dell’Oglio and S. Joniau and M. Bianchi and A. Briganti and M. Spahn and P. Bastian and J. Chun and P. Chlosta and P. Gontero and M. Graefen and Karnes, {Robert Jeffrey} and G. Marchioro and B. Tombal and L. Tosco and {van der Poel}, {H. Henk} and R. Sanchez-Salas",
year = "2016",
month = "2",
day = "20",
doi = "10.1007/s00345-016-1784-8",
language = "English (US)",
pages = "1--6",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy

AU - Sivaraman, A.

AU - Ordaz Jurado, G.

AU - Cathelineau, X.

AU - Barret, Eric

AU - Dell’Oglio, P.

AU - Joniau, S.

AU - Bianchi, M.

AU - Briganti, A.

AU - Spahn, M.

AU - Bastian, P.

AU - Chun, J.

AU - Chlosta, P.

AU - Gontero, P.

AU - Graefen, M.

AU - Karnes, Robert Jeffrey

AU - Marchioro, G.

AU - Tombal, B.

AU - Tosco, L.

AU - van der Poel, H. Henk

AU - Sanchez-Salas, R.

PY - 2016/2/20

Y1 - 2016/2/20

N2 - Introduction: The aim of the study was to identify the appropriate level of Charlson comorbidity index (CCI) in older patients (>70 years) with high-risk prostate cancer (PCa) to achieve survival benefit following radical prostatectomy (RP). Methods: We retrospectively analyzed 1008 older patients (>70 years) who underwent RP with pelvic lymph node dissection for high-risk prostate cancer (preoperative prostate-specific antigen >20 ng/mL or clinical stage ≥T2c or Gleason ≥8) from 14 tertiary institutions between 1988 and 2014. The study population was further grouped into CCI <2 and ≥2 for analysis. Survival rate for each group was estimated with Kaplan–Meier method and competitive risk Fine-Gray regression to estimate the best explanatory multivariable model. Area under the curve (AUC) and Akaike information criterion were used to identify ideal ‘Cut off’ for CCI. Results: The clinical and cancer characteristics were similar between the two groups. Comparison of the survival analysis using the Kaplan–Meier curve between two groups for non-cancer death and survival estimations for 5 and 10 years shows significant worst outcomes for patients with CCI ≥ 2. In multivariate model to decide the appropriate CCI cut-off point, we found CCI 2 has better AUC and p value in log rank test. Conclusion: Older patients with fewer comorbidities harboring high-risk PCa appears to benefit from RP. Sicker patients are more likely to die due to non-prostate cancer-related causes and are less likely to benefit from RP.

AB - Introduction: The aim of the study was to identify the appropriate level of Charlson comorbidity index (CCI) in older patients (>70 years) with high-risk prostate cancer (PCa) to achieve survival benefit following radical prostatectomy (RP). Methods: We retrospectively analyzed 1008 older patients (>70 years) who underwent RP with pelvic lymph node dissection for high-risk prostate cancer (preoperative prostate-specific antigen >20 ng/mL or clinical stage ≥T2c or Gleason ≥8) from 14 tertiary institutions between 1988 and 2014. The study population was further grouped into CCI <2 and ≥2 for analysis. Survival rate for each group was estimated with Kaplan–Meier method and competitive risk Fine-Gray regression to estimate the best explanatory multivariable model. Area under the curve (AUC) and Akaike information criterion were used to identify ideal ‘Cut off’ for CCI. Results: The clinical and cancer characteristics were similar between the two groups. Comparison of the survival analysis using the Kaplan–Meier curve between two groups for non-cancer death and survival estimations for 5 and 10 years shows significant worst outcomes for patients with CCI ≥ 2. In multivariate model to decide the appropriate CCI cut-off point, we found CCI 2 has better AUC and p value in log rank test. Conclusion: Older patients with fewer comorbidities harboring high-risk PCa appears to benefit from RP. Sicker patients are more likely to die due to non-prostate cancer-related causes and are less likely to benefit from RP.

KW - Charlson comorbidity index

KW - High-risk prostate cancer

KW - Radical prostatectomy

KW - Survival benefit

UR - http://www.scopus.com/inward/record.url?scp=84958744104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958744104&partnerID=8YFLogxK

U2 - 10.1007/s00345-016-1784-8

DO - 10.1007/s00345-016-1784-8

M3 - Article

C2 - 26897499

AN - SCOPUS:84958744104

SP - 1

EP - 6

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

ER -